Trytosaveabit commented on a stock · Oct 5, 2023 07:15

News!

$Lineage Cell Therapeutics(LCTX.US)$ Lineage Cell Therapeutics' RG6501 (OpRegen) Phase 1/2a Results Show Evidence of Rapid Improvement of Outer Retinal Structure in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

2762 Views

Comment

Trytosaveabit

1881Followers

30Following

22KVisitors